Search | Clinical Trials Finder

Conditions: Pain
Interventions: Oxymorphone; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip
Interventions: Celecoxib; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 875 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 67
States / cities: Huntsville, Alabama • Peoria, Arizona • Phoenix, Arizona + 58 more

Conditions: Osteoarthritis,Knee, Osteoarthritis Knees Both, Osteoarthritis Hip, Low Back Pain, Chronic Pain, Hip Pain Chronic, Knee Pain Chronic
Interventions: motivational enhancement and planning; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 50 Years and older
Enrollment: 94 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Osteoarthritis
Interventions: Buprenorphine transdermal patch, Placebo; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 529 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 44
States / cities: Mesa, Arizona • Phoenix, Arizona • Tucson, Arizona + 38 more

Conditions: Juvenile; Scoliosis, Scoliosis Idiopathic, Scoliosis; Adolescence, Scoliosis;Congenital, Kyphosis, Spondylolisthesis, Pectus Surgery, Hip Surgery
Interventions: Fast-Dissolve Melatonin Pill, Fast-Dissolve Placebo Pill; Dietary Supplement · Other
Lead sponsor: Stanford University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Hip Pain Chronic
Interventions: Transmuscular Quadratus Lumborum Block, Pericapsular injection, Bupivacaine Hydrochloride; Procedure · Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Pain, Knee Pain Chronic, Hip Pain Chronic, Back Pain
Interventions: Cognitive Training + fMRI; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Cerebral Palsy, Hip Dysplasia, Pain, Postoperative
Interventions: Ropivacaine injection, Bupivacaine, lidocaine, ropivacaine; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Up to 18 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Los Angeles, California • Santa Monica, California • Chicago, Illinois

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Osteo Arthritis Shoulders, Synovitis of Knee, Synovitis/Tenosynovitis - Hip, Synovitis, Pain, Chronic
Interventions: Shoulder/Hip/Knee Embolization with Embozene Microspheres; Device
Lead sponsor: Palo Alto Veterans Institute for Research; Other
Eligibility: 25 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Chronic Pain
Interventions: Tramadol HCl ER; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2003
U.S. locations: 1
States / cities: Duncansville, Pennsylvania

Conditions: Hip Arthritis, Hip Disease, Hip Fractures, Hip Injuries, Hip Pain Chronic
Interventions: RingLoc Bipolar Acetabular Cup, Endo II Femoral Head; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Falls Church, Virginia

Conditions: Osteo Arthritis Knee and Hip, Low Back Pain, Insomnia
Interventions: Aerobic physical activity, CBT-I, Combined aerobic physical activity and CBT-I; Behavioral
Lead sponsor: University of Sydney; Other
Eligibility: 18 Years and older
Enrollment: 384 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: San Antonio, Nevada • San Antonio, Texas

Conditions: Arthritis;Lumbosacral, Osteo Arthritis Knee, Sacroiliitis, Hip Osteoarthritis, Arthritis, Degenerative
Interventions: Cooled radiofrequency ablation; Device
Lead sponsor: International Spine, Pain and Performance Center; Other
Eligibility: 21 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Arlington, Virginia

Conditions: Cerebral Palsy, Hip Dysplasia, Pain, Postoperative
Interventions: Ropivacaine injection, normal saline; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: Up to 18 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: Los Angeles, California • Santa Monica, California • Chicago, Illinois

Conditions: Chronic Hip Joint Pain, Prearthritic Hip Disease
Interventions: Rehabilitation; Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 15 Years to 40 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: St Louis, Missouri • Pittsburgh, Pennsylvania

Conditions: Osteoarthritis
Interventions: Buprenorphine transdermal delivery system; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999
U.S. locations: 22
States / cities: Phoenix, Arizona • Tucson, Arizona • San Diego, California + 16 more

Conditions: Hip Pain Chronic, Hip Disease
Interventions: Patient Self-Administered Diagnostic Exam, Clinician-Performed Diagnostic Exam; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Hip Pain
Interventions: MRI; Diagnostic Test
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis (OA) of the Hip, Osteoarthritis (OA) of the Knee, Osteoarthritis (OA) of the Shoulder, Osteoarthritis, Mild Cognitive Impairment, MCI, Mild Cognitive Impairment (MCI), Dementia
Interventions: Well-formulated ketogenic diet; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 55 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Fairway, Kansas

Conditions: Clinical Decision Making, Nonarthritic Hip Disease
Interventions: Interdisciplinary Evaluation for Nonarthritic Hip Disease, Posture and Movement Training, Treatment-of-choice; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hip Pain Chronic, Hip Impingement Syndrome, Hip Injuries, Blood Loss, Femoro Acetabular Impingement
Interventions: Tranexamic acid, Placebo; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Hip Pain Chronic, Anesthesia, Bupivacaine
Interventions: Fascial iliac regional soft tissue infiltration blockade, Pain Score Survey, Pill Count, Bupivacaine, Liposomal Bupivacaine; Procedure · Behavioral · Drug
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years to 50 Years
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Opioid Use, Opioid Dependence, Knee Pain Chronic, Knee Osteoarthritis
Interventions: Improved Opioid-Tapering Instructions, Clinical Patient Educator; Drug · Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Pain, Chronic Back Pain, Chronic Low Back Pain, Osteoarthritis Pain In The Hip or Knee
Interventions: Nucynta ER; Drug
Lead sponsor: Janssen Scientific Affairs, LLC; Industry
Eligibility: 18 Years to 74 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 7
States / cities: Jacksonville, Florida • Prairie Village, Kansas • Mandeville, Louisiana + 4 more

Search by objective public record fields.

A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)

Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use"

Coach2Move: Physical Therapy to Improve Physical Activity in Individuals With Chronic MSK Conditions

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or Knee

Studying Melatonin and Recovery in Teens

Transmuscular Quadratus Lumborum Block Plus Pericapsular Injection vs Pericapsular Injection

Cognitive Flexibility Training for Persistent Pain: Neuroimaging Pilot (COFLEX-i)

Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

A Study Comparing the Effectiveness and Safety of Varying Dose Strengths (100, 200, 300 and 400 mg) of Extended-release Tramadol HCl With Placebo for the Treatment of Osteoarthritis(OA) of the Knee and/or Hip

MDR - PMCF Study for RingLoc Bipolar Acetabular Cup and Endo II Femoral Heads

COMPARATIVE EFFECTIVENESS OF EXERCISE, COGNITIVE BEHAVIOURAL THERAPY, AND THEIR COMBINATION FOR PEOPLE WITH CHRONIC MUSCULOSKELETAL PAIN AND POOR SLEEP: SLEEPFIT TRIAL

Cooled RF Lesion MRI Characteristics

Peri-operative Use of a Pain Injection in Pediatric Patients With Cerebral Palsy

Movement Pattern Training in People With Intra-articular, Prearthritic Hip Disorders

Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Patient Performed Examination for Patients With Intra-articular Hip Pain

Maveric Magnetic Resonance Imaging Used to Study Detailed Bone Apposition and Fixation of the Stryker Trident II Tritanium System

Ketogenic Diet to Reduce Osteoarthritis Pain in MCI

Nonarthritic Hip Disease Evaluation And Treatment

Tranexamic Acid (TXA) in Hip Arthroscopy

Hip Arthroscopy Pain Control Randomized Control Trial (RCT)

Can Simplified and More Detailed Instructions Affect Post-Operative Narcotic Consumption

An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)